[ Price : $8.95]
An HHS-funded RAND study finds that many new drugs are available in the U.S. before launching in other countries.[ Price : $8.95]
Federal Register notice: FDA issues an order to reduce a five-year debarment against former Indivior global medical director Timot...[ Price : $8.95]
A detailed FDLI analysis looks at how expected Supreme Court changes to the Chevron federal agency deference principle will likely...[ Price : $8.95]
FDA accepts for priority review an Applied Therapeutics NDA for AT-007 (govorestat) for treating classic Galactosemia.[ Price : $8.95]
CBER director Peter Marks says he expects 2024 to be a big year for gene therapy approvals as several Center initiatives take hold...[ Price : $8.95]
Four stakeholders update comments on the latest version of an FDA draft guidance on topical ophthalmic products.[ Price : $8.95]
FDA warns Amman, Jordan-based Amman Pharmaceutical Industries about CGMP violations in its production of drugs as a contract manuf...[ Price : $8.95]
FDA fails to locate the UK-based manufacturer of filthy eye drops, LightEyez, accused of manufacturing and distributing unapproved...